Nihar Ranjan Dash

Dr. Nihar Ranjan Dash

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NDNihar Ranjan Dash
Nihar Ranjan Dash
GKGhalia Khoder
Ghalia Khoder
ANAml Mohamed Nada
Aml Mohamed Nada
MBMohammad Al Bataineh
Mohammad Al Bataineh
Helicobacter pylori (H. pylori) is known to colonize gastric mucosa, induce inflammation, and alter gastric microbiota resulting in a spectrum of gastric diseases. Likewise, changes in gut microbiota have recently been linked with various metabolic and inflammatory diseases. While extensive number of studies were published examining the relationship between H. pylori and gastric microbiota, little is known about the impact of H. pylori on downstream gut microbiota. In this study, we performed 16 S rRNA and ITS2-based microbial profiling analysis of 60 stool samples from adult individuals. Remarkably, the gut microbiota of H. pylori infected individuals was shown to be increased of members belonging to Succinivibrio, Coriobacteriaceae, Enterococcaceae, and Rikenellaceae. Moreover, gut microbiota of H. pylori infected individuals was shown to have increased abundance of Candida glabrata and other unclassified Fungi. These results links possible role for H. pylori-associated changes in the gut microbiota in intestinal mucosal barrier disruption and early stage colorectal carcinoma deployment. Altogether, the identified differences in bacterial and fungal composition provides important information that may eventually lead to the development of novel biomarkers and more effective management strategies.

15 July 2017 in Environmental Science and Pollution Research
Verified
Journal Article
Closed access
PDF file
MHM Bakri Hammami
M Bakri Hammami
EMEman Qasem Mohammed
Eman Qasem Mohammed
AHAnas Mohammad Hashem
Anas Mohammad Hashem
MAMina Amer Al-Khafaji
Mina Amer Al-Khafaji
FAFatima Alqahtani
Fatima Alqahtani
NDNihar Ranjan Dash
Nihar Ranjan Dash

1 June 1999 in Emerging Infectious Diseases
Verified
Journal Article
Open access
SSSeema Sood
Seema Sood
AKArti Kapil
Arti Kapil
NDNihar Ranjan Dash
Nihar Ranjan Dash
BDBimal K. Das
Bimal K. Das
VGVikas Goel
Vikas Goel
PSPradeep Seth
Pradeep Seth

15 June 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MBMohammad Al Bataineh
Mohammad Al Bataineh
NDNihar Ranjan Dash
Nihar Ranjan Dash
PLPierre Bel Lassen
Pierre Bel Lassen
BBBayan Hassan Banimfreg
Bayan Hassan Banimfreg
ANAml Mohamed Nada
Aml Mohamed Nada
KCKarine Clément
Karine Clément
Type 2 diabetes mellitus (T2DM) drastically affects the population of Middle East countries with an ever-increasing number of overweight and obese individuals. The precise links between T2DM and gut microbiome composition remain elusive in these populations. Here, we performed 16 S rRNA and ITS2- gene based microbial profiling of 50 stool samples from Emirati adults with or without T2DM. The four major enterotypes initially described in westernized cohorts were retrieved in this Emirati population. T2DM and non-T2DM healthy controls had different microbiome compositions, with an enrichment in Prevotella enterotype in non-T2DM controls whereas T2DM individuals had a higher proportion of the dysbiotic Bacteroides 2 enterotype. No significant differences in microbial diversity were observed in T2DM individuals after controlling for cofounding factors, contrasting with reports from westernized cohorts. Interestingly, fungal diversity was significantly decreased in Bacteroides 2 enterotype. Functional profiling from 16 S rRNA gene data showed marked differences between T2DM and non-T2DM controls, with an enrichment in amino acid degradation and LPS-related modules in T2DM individuals, whereas non-T2DM controls had increased abundance of carbohydrate degradation modules in concordance with enterotype composition. These differences provide an insight into gut microbiome composition in Emirati population and its potential role in the development of diabetes mellitus.

31 January 2021 in Diabetes & Metabolism Journal
Verified
Journal Article
Open access
PDF file
NDNihar Ranjan Dash
Nihar Ranjan Dash
MBMohammad Al Bataineh
Mohammad Al Bataineh
Dash NR, et al. Diabetes Metab J. 2020 Jan;44:e23. https://doi.org/10.4093/dmj.2019.0202

22 September 2020 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
MBMohammad Al Bataineh
Mohammad Al Bataineh
RHRifat A. Hamoudi
Rifat A. Hamoudi
NDNihar Ranjan Dash
Nihar Ranjan Dash
RRRakhee K. Ramakrishnan
Rakhee K. Ramakrishnan
MAMohamad A. Almasalmeh
Mohamad A. Almasalmeh
QHQutayba Hamid
Qutayba Hamid
Background: The microbiota of the respiratory tract has an important role in maintaining respiratory health. However, little is known on the respiratory microbiota in asthmatic patients among Middle Eastern populations. This study investigated the respiratory microbiota composition and functionality associated with asthma in Emirati subjects. Methods: We performed 16S rRNA and ITS2-gene based microbial profiling of 40 expectorated sputum samples from adult and pediatric Emirati individuals averaging 52 and 7 years of age, respectively with or without asthma. Results: We report bacterial difference belonging to Bacteroidetes, Firmicutes, Fusobacteria and Proteobacteria phyla between asthmatic and non-asthmatic controls. Similarly, fungal difference belonging to Ascomycota, Basidiomycota phyla and other unclassified fungi. Differential abundance testing among asthmatic individuals with relation to Asthma Control Test show a significant depletion of Penicillium aethiopicum and Alternaria spp., among poorly controlled asthmatics. Moreover, data suggest a significant expansion of Malassezia spp. and other unclassified fungi in the airways of those receiving steroids and leukotriene receptor antagonists’ combination therapy, in contrast to those receiving steroids alone. Functional profiling from 16S data showed marked differences between pediatric asthmatic and non-asthmatic controls, with pediatric asthmatic patients showing an increase in amino acid (p-value < 5.03 × 10− 7), carbohydrate (p-value < 4.76 × 10− 7), and fatty acid degradation (p-value < 6.65 × 10− 7) pathways, whereas non-asthmatic controls are associated with increase in amino acid (p-value < 8.34 × 10− 7), carbohydrate (p-value < 3.65 × 10− 7), and fatty acid (p-value < 2.18 × 10− 6) biosynthesis pathways in concordance with enterotype composition. Conclusions: These differences provide an insight into respiratory microbiota composition in Emirati population and its possible role in the development of asthma early in life. This study provides important information that may eventually lead to the development of screening biomarkers to predict early asthma development and novel therapeutic approaches.